Francesca Cordeiro, PhD, MD, FRCOphth, on predicting GA progression with DARC | EURETINA 2026

At the 26th EURETINA Congress in Vienna, Francesca Cordeiro, PhD, MD, FRCOphth, founder and CEO of Novai Ltd and chair of ophthalmology at Imperial College London, discusses a newly published paper on Detection of Apoptosing Retinal Cells (DARC) in geographic atrophy. She explains how a single DARC scan predicted the speed and direction of atrophy growth up to 4 years later. She also covers how DARC could stratify patients by risk of vision loss, help pharmaceutical companies de-risk GA drug development, and eventually serve as a screening tool for retinal and neurodegenerative disease. #EURETINA2026 #GeographicAtrophy #DARC #Retina #AMD #Ophthalmology #OphthalmologyTimesEurope